ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 40059633

Impact of Minimal Residual Disease on Early Recurrence of Liver Metastatic Colorectal Cancer.

Kawashima M and 10 others. Cancer Sci, 2025. Cited by 5 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Impact of Minimal Residual Disease on Early Recurrence of Liver Metastatic Colorectal Cancer. Papers, record 40059633. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40059633

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of Minimal Residual Disease on Early Recurrence of Liver Metastatic Colorectal Cancer.
PubMed
Journal
Cancer Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Observational Study
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.31, provisional
iCite
Revised in PubMed
2025-05-06
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kawashima MMampeihttps://orcid.org/0000-0001-7306-728X
2Yamada TTakeshihttps://orcid.org/0000-0002-1436-7482
3Miyasaka TToshimitsuhttps://orcid.org/0000-0003-4066-0479
4Kanaka SShintaro
5Kuriyama SSho
6Uehara KKay
7Matsuda AAkihisa
8Ohta RRyohttps://orcid.org/0000-0003-2627-2859
9Sonoda HHiromichi
10Taniai NNobuhiko

1 to 10 of 11Source PubMed

See all 11 authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colorectal NeoplasmsMajor topic
Neoplasm, ResidualMajor topic
Liver NeoplasmsMajor topic
Neoplasm Recurrence, LocalMajor topic
Humans
Female
Male
Middle Aged
Aged
Circulating Tumor DNA
Adult
Prognosis
Chemotherapy, Adjuvant
Biomarkers, Tumor
Mutation
Aged, 80 and over

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
23K08182Japan Society for the Promotion of SciencePubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128,210,698Circulating Tumor DNA Analysis for Liver Cancers and Its Usefulness as a Liquid Biopsy.Cell Mol Gastroenterol Hepatol2015https://conductscience.org/library/papers/28210698PubMed
224,120,480Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.Lancet Oncol2013https://conductscience.org/library/papers/24120480PubMed
331,427,281Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.Clin Cancer Res2019https://conductscience.org/library/papers/31427281PubMed
428,600,478Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer.Clin Cancer Res2017https://conductscience.org/library/papers/28600478PubMed
529,452,859Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.Eur J Surg Oncol2018https://conductscience.org/library/papers/29452859PubMed
638,639,939ICG-Fluorescence Imaging for Margin Assessment During Minimally Invasive Colorectal Liver Metastasis Resection.JAMA Netw Open2024https://conductscience.org/library/papers/38639939PubMed
731,015,557A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer.Br J Cancer2019https://conductscience.org/library/papers/31015557PubMed
836,127,553Survival by Number and Sites of Resections of Recurrence after First Curative Resection of Colorectal Liver Metastases.J Gastrointest Surg2022https://conductscience.org/library/papers/36127553PubMed
927,588,959Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.PLoS One2016https://conductscience.org/library/papers/27588959PubMed
1032,393,783Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer.Cell Death Dis2020https://conductscience.org/library/papers/32393783PubMed

1 to 10 of 30

See all 30 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42,938,840Circulating Tumor DNA in Resected Colorectal Liver Metastases: From Minimal Residual Disease Detection to Treatment Guidance-A Systematic Review.Cancers (Basel)2026https://conductscience.org/library/papers/42938840PubMed
42,827,738Efficacy of circulating tumour DNA in guiding postoperative adjuvant chemotherapy for resectable colorectal cancer: A meta-analysis based on cohort studies.Oncol Lett2026https://conductscience.org/library/papers/42827738PubMed
42,668,443Impact of methodological variability on the prognostic performance of circulating tumor DNA in colorectal cancer: A systematic review and meta-analysis.J Liq Biopsy2026https://conductscience.org/library/papers/42668443PubMed
42,588,662Factors Associated with the Timing of Liver Metastasis After Colorectal Cancer Surgery: A Retrospective Multicenter Study.Cancers (Basel)2026https://conductscience.org/library/papers/42588662PubMed
42,379,715
Circulating tumour DNA in patients with colorectal cancer undergoing curative-intent LIver MEtastases Surgery in France: a prospective, multicentre GERCOR G-118 CLIMES PRODIGE 77 cohort study protocol.
BMJ Open2026https://conductscience.org/library/papers/42379715PubMed
41,906,796Utility of Urinary Extracellular Vesicles for Colorectal Cancer: Comparison of DNA Quality and MRD Detection.Cancer Sci2026https://conductscience.org/library/papers/41906796PubMed

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40059633

GET https://conductscience.org/api/papers/v1/40059633/references?page=2

API referenceFor AI assistants